Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Nature Reviews. Drug Discovery
|
March 2, 2012
Market watch: industry perspectives on personalized medicine
Rachael Zuckerman, Christopher-Paul Milne
Personalized Medicine
|
May 26, 2018
Biopharmaceutical industry perspectives on the business prospects for personalized medicine
Christopher-Paul Milne, Rachael Zuckerman
Drug Information Journal
|
June 1, 2011
A New Mechanism for Tracking Publicly Available Study Volunteer Demographics
Rachael Zuckerman, Kenneth Getz, Kenneth Kaitin
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
|
May 12, 2016
Hospice Use, Hospitalization, and Medicare Spending at the End of Life
Rachael Zuckerman, Sally Stearns, Steven Sheingold
Health Affairs (Project Hope)
|
January 7, 2016
Understanding Medicare Hospital Readmission Rates And Differing Penalties Between Safety-Net And Other Hospitals
Steven H Sheingold, Rachael Zuckerman, Adele Shartzer
Circulation. Cardiovascular Quality and Outcomes
|
May 17, 2017
Social Risk Factors and Performance Under Medicare's Value-Based Purchasing Programs
Karen E Joynt, Rachael Zuckerman, Arnold M Epstein
JAMA Network Open
|
July 6, 2026
Postacute COVID-19 Symptoms and Health Care Utilization and Spending Among Traditional Medicare Beneficiaries
Kaushik Ghosh, Rachael Zuckerman, Yevgeniy Feyman, et al.
Journal of the American Geriatrics Society
|
October 5, 2017
Association Between Race, Neighborhood, and Medicaid Enrollment and Outcomes in Medicare Home Health Care
Karen E Joynt Maddox, Lena M Chen, Rachael Zuckerman, et al.
Health Affairs (Project Hope)
|
June 7, 2021
COVID-19-Related Deaths And Excess Deaths Among Medicare Fee-For-Service Beneficiaries
Wafa W Tarazi, Kenneth Finegold, Steven H Sheingold, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Nature Reviews. Drug Discovery
|
March 2, 2012
Market watch: industry perspectives on personalized medicine
Rachael Zuckerman, Christopher-Paul Milne
Personalized Medicine
|
May 26, 2018
Biopharmaceutical industry perspectives on the business prospects for personalized medicine
Christopher-Paul Milne, Rachael Zuckerman
Drug Information Journal
|
June 1, 2011
A New Mechanism for Tracking Publicly Available Study Volunteer Demographics
Rachael Zuckerman, Kenneth Getz, Kenneth Kaitin
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
|
May 12, 2016
Hospice Use, Hospitalization, and Medicare Spending at the End of Life
Rachael Zuckerman, Sally Stearns, Steven Sheingold
Health Affairs (Project Hope)
|
January 7, 2016
Understanding Medicare Hospital Readmission Rates And Differing Penalties Between Safety-Net And Other Hospitals
Steven H Sheingold, Rachael Zuckerman, Adele Shartzer
Circulation. Cardiovascular Quality and Outcomes
|
May 17, 2017
Social Risk Factors and Performance Under Medicare's Value-Based Purchasing Programs
Karen E Joynt, Rachael Zuckerman, Arnold M Epstein
JAMA Network Open
|
July 6, 2026
Postacute COVID-19 Symptoms and Health Care Utilization and Spending Among Traditional Medicare Beneficiaries
Kaushik Ghosh, Rachael Zuckerman, Yevgeniy Feyman, et al.
Journal of the American Geriatrics Society
|
October 5, 2017
Association Between Race, Neighborhood, and Medicaid Enrollment and Outcomes in Medicare Home Health Care
Karen E Joynt Maddox, Lena M Chen, Rachael Zuckerman, et al.
Health Affairs (Project Hope)
|
June 7, 2021
COVID-19-Related Deaths And Excess Deaths Among Medicare Fee-For-Service Beneficiaries
Wafa W Tarazi, Kenneth Finegold, Steven H Sheingold, et al.
Page
of 1